Topic

Washington

A collection of 516 issues

How to Get Opdivo (Nivolumab) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Opdivo Covered by Cigna in Washington Cigna requires prior authorization for Opdivo (nivolumab) with specific medical necessity criteria. Your fastest path: Have your oncologist submit a complete PA request through CoverMyMeds or Cigna's provider portal including diagnosis, staging, biomarker results, and prior treatment history. If

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by Aetna CVS Health in Washington: Complete Prior Authorization Guide

Answer Box: Getting Lutathera Covered by Aetna CVS Health in Washington Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Aetna CVS Health. The fastest path to approval: 1) Verify your plan's formulary status and PA requirements through the Aetna member portal, 2) Submit a complete PA request with

How to Get Tremfya (guselkumab) Covered by Aetna in Washington: Appeals Guide with State Protections

Answer Box: Getting Tremfya (guselkumab) Covered by Aetna in Washington Fastest path to approval: Submit Aetna's prior authorization form with specialist documentation of diagnosis severity, prior treatment failures, and medical necessity. If denied, use Washington's internal appeal (180 days) followed by independent review organization (IRO) process

How to Get Fabrazyme (agalsidase beta) Covered by Aetna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Fabrazyme (agalsidase beta) requires prior authorization from Aetna in Washington. Your fastest path: 1) Have your specialist complete Aetna's PA form with genetic testing results and organ involvement documentation, 2) Submit via provider portal or fax, and 3) If denied, file internal appeal within 60-180 days,

Requirements Checklist to Get Kesimpta (Ofatumumab) Covered by UnitedHealthcare in Washington: Forms, Appeals & Timelines

Quick Answer: Getting Kesimpta Covered by UnitedHealthcare in Washington Eligibility: Adults with relapsing MS (RRMS, CIS, active SPMS) who need prior authorization through OptumRx. Fastest path: Submit complete PA with documented step therapy failures or contraindications. Start today: Call UnitedHealthcare at the number on your card to verify Kesimpta'

How to Get Givlaari (Givosiran) Covered by Aetna CVS Health in Washington: Complete Forms, Appeals Guide & Contact Numbers

Quick Answer: Getting Givlaari (Givosiran) Covered by Aetna CVS Health in Washington Path to approval: Submit Aetna's Givlaari precertification form with biochemical confirmation (elevated ALA/PBG levels), documented attack history (≥2 qualifying attacks in 6-12 months), and specialist evaluation. If denied, file internal appeal within 180 days, then

How to Get Amondys 45 (casimersen) Covered by Cigna in Washington: Complete Forms, Appeals & Genetic Testing Guide

Quick Answer: Getting Amondys 45 (casimersen) Covered by Cigna in Washington Eligibility: Cigna covers Amondys 45 for DMD patients with confirmed exon 45-amenable mutations through prior authorization. Fastest path: Have your neuromuscular specialist submit genetic test results plus clinical documentation to Cigna's specialty pharmacy team. Start today: Call

UnitedHealthcare Coverage for Oxbryta (Voxelotor) in Washington: 2024 FDA Withdrawal and Alternative Options

Answer Box: Oxbryta Coverage Status Oxbryta (voxelotor) is no longer available and cannot be covered by UnitedHealthcare or any insurer. Pfizer voluntarily withdrew the drug in September 2024 following FDA safety review. Your fastest path forward: Work with your hematologist to transition to FDA-approved alternatives like hydroxyurea, L-glutamine, or crizanlizumab.

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Washington: Complete 2025 Discontinuation Guide

Answer Box: Getting Natpara Covered by Cigna in Washington Critical Update: Natpara was discontinued by Takeda on December 31, 2024. Existing patients have access through the Special Use Program until December 31, 2025, but new prescriptions are generally denied due to lack of commercial supply. For current patients: Submit prior

Coding That Helps Get Jaypirca (Pirtobrutinib) Approved by Aetna (CVS Health) in Washington: ICD-10, HCPCS J-Code, and NDC Guide

Answer Box: Getting Jaypirca (Pirtobrutinib) Approved by Aetna (CVS Health) in Washington Key codes needed: ICD-10 C83.1 (mantle cell lymphoma) or C91.1/C83.0 (CLL/SLL) with relapse status; HCPCS J9399; NDC varies by strength. Fastest approval path: Submit prior authorization through CVS Caremark with complete documentation of